Target intelligence / Profile preview

Glutamate receptor ionotropic, kainate 1 (GluK1) (GluK1)

Target
GluK1
Molecular classification
Ion channel, Glutamate receptor, Kainate receptor, Ligand-gated ion channel
01

Overview

Glutamate receptor ionotropic, kainate 1 (GluK1) is a protein encoded by the GRIK1 gene and is a member of the ionotropic glutamate receptor family [1, 3]. It functions as a ligand-gated ion channel that mediates excitatory neurotransmission in the central and peripheral nervous systems by allowing the influx of cations upon binding glutamate or kainate [3, 6]. Beyond its canonical ionotropic role, GluK1 is involved in noncanonical metabotropic signaling through coupling with G-proteins, specifically Go, which modulates the release of other neurotransmitters like GABA and glutamate [5, 15]. GluK1 is highly expressed in areas such as the hippocampus, amygdala, and dorsal root ganglia, making it a key player in synaptic plasticity and sensory processing [9, 11]. It is a significant therapeutic target for neurological and psychiatric disorders, including epilepsy, chronic pain, migraine, and alcohol use disorder [5, 8, 11]. Pharmacological modulation of GluK1, particularly through selective antagonists, aims to reduce neuronal hyperexcitability and has demonstrated efficacy in preclinical models for treating seizures and nociception [11, 14].

Other names
GRIK1GluR5EAA3GLUR5GluR-5EEA3GLR5
02

Mechanism of action

Antagonist, Agonist, Allosteric modulator

03

Biological functions

Signal transductionSynaptic transmissionNeurotransmissionIon transmembrane transportMetabotropic signaling
04

Disease associations

EpilepsyPainMigraineSchizophreniaAutismAlcohol use disorderNeurodegenerative disease
05

Safety considerations

Cognitive impairmentSedationParesthesiaMotor coordination issues
06

Interacting drugs

Topiramate

8 more in the full profile.

07

Biomarkers

GRIK1 genetic variantsRNA editing (Q/R site)

Beyond the preview

Go deeper on Glutamate receptor ionotropic, kainate 1 (GluK1) (GluK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate receptor ionotropic, kainate 1 (GluK1) (GluK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call